157 related articles for article (PubMed ID: 3113299)
1. [Anti-activator inhibitors of plasminogen].
Juhan-Vague I; Alessi MC; Aillaud MF
Ann Biol Clin (Paris); 1987; 45(2):202-6. PubMed ID: 3113299
[TBL] [Abstract][Full Text] [Related]
2. [Thromboembolic disease and anomalies of fibrinolysis].
Juhan-Vague I; Aillaud MF; Valadier J; Alessi MC; Serradimigni A
Ann Med Interne (Paris); 1986; 137(6):471-4. PubMed ID: 3101564
[TBL] [Abstract][Full Text] [Related]
3. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
Juhan-Vague I; Vague P; Alessi MC; Badier C; Valadier J; Aillaud MF; Atlan C
Diabete Metab; 1987 Jul; 13(3 Pt 2):331-6. PubMed ID: 3115843
[TBL] [Abstract][Full Text] [Related]
4. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
Verheijen JH; Rijken DC; Chang GT; Preston FE; Kluft C
Thromb Haemost; 1984 Jul; 51(3):396-7. PubMed ID: 6437007
[TBL] [Abstract][Full Text] [Related]
5. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.
Sprengers ED; Akkerman JW; Jansen BG
Thromb Haemost; 1986 Jun; 55(3):325-9. PubMed ID: 3092389
[TBL] [Abstract][Full Text] [Related]
6. A sensitive assay, specific for endothelial cell type plasminogen activator inhibitor in blood plasma.
Sprengers ED
Thromb Haemost; 1986 Feb; 55(1):74-7. PubMed ID: 3085268
[TBL] [Abstract][Full Text] [Related]
7. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
Félez J; Rueda F
Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
[No Abstract] [Full Text] [Related]
9. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
Kluft C; Jie AF; Rijken DC; Verheijen JH
Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814
[TBL] [Abstract][Full Text] [Related]
10. Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age.
Aillaud MF; Pignol F; Alessi MC; Harle JR; Escande M; Mongin M; Juhan-Vague I
Thromb Haemost; 1986 Jun; 55(3):330-2. PubMed ID: 3092390
[TBL] [Abstract][Full Text] [Related]
11. Masking of fibrinolytic response to stimulation by an inhibitor of tissue-type plasminogen activator in plasma.
Brommer EJ; Verheijen JH; Chang GT; Rijken DC
Thromb Haemost; 1984 Oct; 52(2):154-6. PubMed ID: 6441302
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
[TBL] [Abstract][Full Text] [Related]
13. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
[TBL] [Abstract][Full Text] [Related]
14. Increased PA-inhibitor levels in the postoperative period--no cause-effect relation with increased cortisol.
Aillaud MF; Juhan-Vague I; Alessi MC; Marecal M; Vinson MF; Arnaud C; Vague P; Collen D
Thromb Haemost; 1985 Aug; 54(2):466-8. PubMed ID: 2417352
[TBL] [Abstract][Full Text] [Related]
15. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
Francis RB; McGehee WG; Feinstein DI
Thromb Haemost; 1988 Jun; 59(3):412-4. PubMed ID: 3142079
[TBL] [Abstract][Full Text] [Related]
16. Plasma fibrinolytic activity in patients undergoing major abdominal surgery.
Mellbring G; Dahlgren S; Wiman B
Acta Chir Scand; 1985; 151(2):109-14. PubMed ID: 3873768
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.
Verheijen JH; Chang GT; Kluft C
Thromb Haemost; 1984 Jul; 51(3):392-5. PubMed ID: 6437006
[TBL] [Abstract][Full Text] [Related]
18. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
Páramo JA; Alfaro MJ; Rocha E
Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269
[TBL] [Abstract][Full Text] [Related]
19. A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy.
Booth NA; Reith A; Bennett B
Thromb Haemost; 1988 Feb; 59(1):77-9. PubMed ID: 3129811
[TBL] [Abstract][Full Text] [Related]
20. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
Thromb Haemost; 1988 Oct; 60(2):247-50. PubMed ID: 3146141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
